CKMT2 functions as a novel oncogenic gene in osteosarcoma, revealed by bioinformatics and experimental approaches

Xuefei Wu, Fei Ding, Weijie Wu, Honghua Dong · 2026

Read CKMT2 functions as a novel oncogenic gene in osteosarcoma, revealed by bioinformatics and experimental approaches by Xuefei Wu, Fei Ding, Weijie Wu, Honghua Dong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13462118.txt.

Description

Xuefei Wu and colleagues report, in a 2026 study, that the cell energy protein CKMT2 acts as a cancer driver in osteosarcoma, the most common primary bone cancer in teenagers. How this bone cancer starts and grows is poorly understood. CKMT2 was tied to tumor progress in other cancers. The team mined public gene data, measured it in bone cancer cells, and silenced it in a cell line.

CKMT2 ran high in tumor tissue and marked patients with worse outlook, an independent risk factor in survival models. A prediction chart joining CKMT2 with traits was built. Silencing the gene in cancer cells slowed growth, movement, and invasion. Pathway analysis pointed to energy metabolism, above all pyruvate handling. Silenced cells held less of two proteins, and less pyruvate and lactate. CKMT2 levels tracked with immune cells inside tumors. The authors name it a promising marker and drug target.

Catalog record

CREATORXuefei Wu, Fei Ding, Weijie Wu, Honghua Dong
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35219
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13462118

Browse the full library · About the Tower of Babel